You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》康方生物(09926.HK)暗盘高开30%报21元
阿思达克 04-23 16:33
根据辉立交易平台显示,明天挂牌的康方生物-B(09926.HK)暗盘高开近30%报21元,最高暂见23.8元,现造23.65元,较上市价16.18元,高46%,成交834万股。

康方是一家临床阶段生物制药公司,致力於自主发现、开发及商业化首创及同类最佳疗法,公司专注於满足肿瘤、免疫及其他治疗领域在全球未决医疗需求。是次上市共发售1.59亿股,并已引入包括富达投资、Lake Bleu Prime Healthcare Master Funds、奥博资本、Boyu Capital Opportunities Master Fund、Hudson Bay Master Fund及国企结构调整基金等9名基石投资者,合共认购7,867.2万股,其中前两者认购所占份额最大,分别认购3,137.3万股及2,172万股;10%公开发售获638.2倍超购,冻资逾1,666亿元,成为今年新股「冻资王」,故已启动回拨机制占比增至50%,认购一手中签率仅12%;股份以招股范围(14.88-16.18元)上限定价,料集资净额24.37亿元,主要用作产品研发和商业化、以及在中国广州及中山发展生产及研发设施等。上市联席保荐人分别为大摩及摩通。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account